Skip to Content
Course

Modern -Omics: Technologies and Applications

BIOL-40374

This course provides a comprehensive overview of modern “-Omics”. Students will learn about the underlying technology (instrumentation and laboratory techniques), data types, and discuss how omics approaches are broadly applied to advance medicine and biotechnology. This course also lays the essential scientific foundations for pursuing additional training in bioinformatics or computational biology.

By the end of the course, students will: 

  • Summarize the major branches of -Omics
  • Explain the underlying biological phenomena studied by -Omics
  • Understand the underlying technologies that make -Omics possible
  • Recognize and interpret key data types generated in -Omics experiments
  • Describe key applications of -Omics approaches in medicine and biotechnology
  • Pursue additional training in bioinformatics or computational biology

Course Information

Online
3.00 units
$725.00

Course sessions

Add To Cart

Section ID:

187101

Class type:

Online Asynchronous.

This course is entirely web-based and to be completed asynchronously between the published course start and end dates. Synchronous attendance is NOT required.
You will have access to your online course on the published start date OR 1 business day after your enrollment is confirmed if you enroll on or after the published start date.

Textbooks:

All course materials are included unless otherwise stated.

Policies:

  • No refunds after: 4/14/2025

Schedule:

No information available at this time.
Add To Cart

Instructor: Matthew Weinstock

Matthew Weinstock

Matthew Weinstock is a Group Leader at the biotechnology company AbSci where he is currently leading a team of scientists in the Molecular Sciences group in developing bacterial strains to produce complex biopharmaceuticals.  Previously he was a scientist at Synthetic Genomics, Inc. where he focused on large-scale genome engineering of novel microorganisms for biotech applications. He earned his Ph.D. in biochemistry from the University of Utah, where he worked on the discovery and development of mirror-image peptide therapeutics for emerging infectious diseases.
 

Full Bio